Pethema Foundation
Clinical trials sponsored by Pethema Foundation, explained in plain language.
-
New drug cocktail tested in fight against bone marrow cancer
Disease control OngoingThis study is testing the safety and effectiveness of adding a new drug, belantamab mafodotin, to a standard three-drug combination (VRd) for people newly diagnosed with multiple myeloma who are eligible for a stem cell transplant. The goal is to see if this four-drug combination…
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug cocktail tested for patients out of options
Disease control OngoingThis study is testing a combination of four drugs (selinexor, bortezomib, dexamethasone, and daratumumab) for people with multiple myeloma that has come back or stopped responding to other treatments. The goal is to see if this new combination can help control the cancer. About 6…
Phase: PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC